Literature DB >> 16105711

Multivalent liposome-based vaccines containing different serosubtypes of PorA protein induce cross-protective bactericidal immune responses against Neisseria meningitidis.

Holly E Humphries1, Jeannette N Williams, Ramona Blackstone, Keith A Jolley, Ho M Yuen, Myron Christodoulides, John E Heckels.   

Abstract

Four serosubtypes (P1.7, 16, P1.7-2, 4, P1.19, 15 and P1.5-1, 10-4) of the PorA outer-membrane protein of Neisseria meningitidis were purified as recombinant proteins and incorporated into liposomes to investigate their immunogenicity. Each serosubtype induced high levels of bactericidal activity against the homologous strain. In addition, liposome preparations containing multiple serosubtypes induced high levels of bactericidal activity against each of the four strains. Significantly, antisera raised against monovalent and multivalent liposomes also showed cross-reactive bactericidal activity against heterologous strains. These data demonstrate that multivalent liposome vaccines, containing multiple PorA serosubtypes, have the potential to provide protection against a broad range of meningococcal strains.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16105711     DOI: 10.1016/j.vaccine.2005.07.056

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  14 in total

Review 1.  Design considerations for liposomal vaccines: influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens.

Authors:  Douglas S Watson; Aaron N Endsley; Leaf Huang
Journal:  Vaccine       Date:  2012-02-02       Impact factor: 3.641

2.  Functional and specific antibody responses in adult volunteers in new zealand who were given one of two different meningococcal serogroup B outer membrane vesicle vaccines.

Authors:  E Wedege; K Bolstad; A Aase; T K Herstad; L McCallum; E Rosenqvist; P Oster; D Martin
Journal:  Clin Vaccine Immunol       Date:  2007-05-09

3.  Porin activity of Anaplasma phagocytophilum outer membrane fraction and purified P44.

Authors:  Haibin Huang; Xueqi Wang; Takane Kikuchi; Yumi Kumagai; Yasuko Rikihisa
Journal:  J Bacteriol       Date:  2006-12-15       Impact factor: 3.490

Review 4.  Emerging research and clinical development trends of liposome and lipid nanoparticle drug delivery systems.

Authors:  John C Kraft; Jennifer P Freeling; Ziyao Wang; Rodney J Y Ho
Journal:  J Pharm Sci       Date:  2013-11-25       Impact factor: 3.534

5.  The Neisseria meningitidis macrophage infectivity potentiator protein induces cross-strain serum bactericidal activity and is a potential serogroup B vaccine candidate.

Authors:  Miao-Chiu Hung; Omar Salim; Jeannette N Williams; John E Heckels; Myron Christodoulides
Journal:  Infect Immun       Date:  2011-06-27       Impact factor: 3.441

6.  Alphavirus-adjuvanted norovirus-like particle vaccines: heterologous, humoral, and mucosal immune responses protect against murine norovirus challenge.

Authors:  Anna D LoBue; Joseph M Thompson; Lisa Lindesmith; Robert E Johnston; Ralph S Baric
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

7.  Multivalent Interactions: Synthesis and Evaluation of Melanotropin Multimers - Tools for Melanoma Targeting.

Authors:  Nabila Brabez; Kara Saunders; Kevin L Nguyen; Thanuja B M Jayasundera; Craig Weber; Ronald M Lynch; Gerard Chassaing; Solange Lavielle; Victor J Hruby
Journal:  ACS Med Chem Lett       Date:  2012-11-24       Impact factor: 4.345

8.  The influence of genomics and proteomics on the development of potential vaccines against meningococcal infection.

Authors:  John E Heckels; Jeannette N Williams
Journal:  Genome Med       Date:  2010-07-22       Impact factor: 11.117

9.  Expression and porin activity of P28 and OMP-1F during intracellular Ehrlichia chaffeensis development.

Authors:  Yumi Kumagai; Haibin Huang; Yasuko Rikihisa
Journal:  J Bacteriol       Date:  2008-03-21       Impact factor: 3.490

10.  A DNA fusion vaccine induces bactericidal antibodies to a peptide epitope from the PorA porin of Neisseria meningitidis.

Authors:  Delin Zhu; Jeannette N Williams; Jason Rice; Freda K Stevenson; John E Heckels; Myron Christodoulides
Journal:  Infect Immun       Date:  2007-10-29       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.